Research and Markets: US Healthcare BPO Market Report 2013-2018: Payer, Provider and Pharmaceuticals
<0> Research and MarketsLaura Wood, Senior Manager.U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0>
() has announced the addition of the report to their offering.
The US healthcare BPO market is undergoing significant transformation with the changing landscape of the US healthcare system. The US pharmaceutical outsourcing market is the largest market in terms of market value, followed by payer and provider outsourcing. The U.S. provider outsourcing market is the fastest-growing segment of the US healthcare BPO market, owing to the implementation of the ICD-10 conversion reform and the shortage of skilled personnel, particularly medical coders in the US.
The U.S. healthcare payer market has been greatly impacted by the introduction of the Patient Protection and Affordable Care Act (PPACA). This market is particularly driven by claims processing services. As the act expanded insurance access to more than 30 million US citizens, the increased claims processing workload led to large-scale outsourcing of these services by payers. Medical billing dominates the US healthcare provider outsourcing market, while contract manufacturing organizations hold the largest share in the US pharmaceutical outsourcing market in the year 2013.
2 Executive Summary
3 Market Overview
4 U.S. Healthcare Payer Outsourcing Market, By Services
5 U.S. Healthcare Provider Outsourcing Market, By Services
6 U.S. Pharmaceutical Outsourcing Market, By Type
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles - Overview, Financials, Services, Strategy & Development
9.1 Accenture Plc
9.2 Accretive Health, Inc.
9.3 Anthelio Healthcare Solutions, Inc.
9.4 Boehringer Ingelheim Gmbh
9.5 Catalent Pharma Solutions, Inc.
9.6 Cognizant Technology Solutions Corporation
9.7 Covance, Inc.
9.8 GEBBS Healthcare Solutions, Inc.
9.9 Genpact Limited
9.10 IBM Corporation
9.11 ICON Plc
9.12 Infosys Bpo Limited
9.13 LONZA Group Ltd.
9.14 Parexel International Corporation
9.15 Quintiles Transnational Holdings, Inc.
9.16 WNS (Holdings) Limited
For more information visit